In order to put final products on the market, companies often need huge research teams that apart from their benefit, may also be a burden for the company. In that aim, we invite companies to externally collaborate with our team with a guaranteed 100 % confidentiality of the obtained results. Furthermore, we are open to provide commercial services to scientific research teams who prefer commercial services over joint publications. We offer numerous services that are crucial in drug design (Ligand Based Drug Design - LBDD and Structural Based Drug Design - SBDD), protein and nucleic acid structure determination, design of new proteins/enzymes and nucleic acids, vaccine design, in silico ADMETox analysis, metabolic pathways, etc. Our expertise combines high quality in silico methods with up-to-date knowledge and experience to give the best possible results. Our molecular modelling services offer reliable and accurate results that will help you take your project to the next level. Please refer to Our Expertise and References sections for detail information regarding our research possibilities.

​

Through a network of our collaborators, we are able to provide synthesis and analysis of antiproliferative activity of newly designed compounds against numerous cell lines including K562, HL 60, Jurkat, RAJI, PC 3, HT-29, MCF-7, MDA-MB 231, HeLa, Hs 294T, A549, as well as normal cell line MRC-5.